# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-22-000108
Filing Date
2022-08-08
Accepted
2022-08-08 08:01:26
Documents
81
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sesn-20220630.htm iXBRL | 10-Q | 1387805
| Complete submission text file | 0001485003-22-000108.txt |  | 6911101

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sesn-20220630.xsd | EX-101.SCH | 58107
3 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sesn-20220630_cal.xml | EX-101.CAL | 53279
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sesn-20220630_def.xml | EX-101.DEF | 257105
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sesn-20220630_lab.xml | EX-101.LAB | 650068
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sesn-20220630_pre.xml | EX-101.PRE | 430487
75 | EXTRACTED XBRL INSTANCE DOCUMENT | sesn-20220630_htm.xml | XML | 1007977

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 221142608
SIC: 2834 Pharmaceutical Preparations